Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Usana Health Sciences Inc publishes a filing, an earnings call transcript or a press release.

Get USNA alerts

About Doug Hekking

Doug Hekking is recorded as CFO at Usana Health Sciences Inc (USNA). Doug Hekking has spoken on 19 earnings calls across 1 company, most recently for Usana Health Sciences Inc on August 5, 2026. Usana Health Sciences Inc is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Usana Health Sciences Inc includes Kevin Guest (Chairman), Frederic Winssinger (Board Member), Gilbert A. Fuller (Board Member) and 7 others.

Doug Hekking on recent calls

“There are two primary drivers that impacted this quarter's results that I want to briefly discuss. First, the company recorded an estimated preliminary non-cash goodwill impairment charge of $29 million related to the higher reporting unit.”
CFO, Q2 2026 USANA Health Sciences Earnings Conference Call ·
“As Kevin alluded to and Walter kind of contributed as well, HIA is diversifying within its own channel, and it had the initial foray into retail towards the latter part of the quarter and also entered both Canada and the U.K. And so those things consume some operational resources as well.”
CFO, Q1 2026 USANA Health Sciences Earnings Conference Call ·
“Just for context, and we talked about a little bit of this in the prerelease. When you roll a lot of information out, as Jim said, it takes some time to process.”
CFO, Usana Health Sciences Inc Q3 FY2025 Earnings Call ·
“I think the timing, you'll see that systematically kind of happen over the year. They have a plan for a fairly meaningful launch of a new relationship at the beginning of May.”
CFO, Usana Health Sciences Inc Q1 FY2025 Earnings Call ·
“As we evaluated the acquisition and the models, when we announced we wanted to be thoughtful in our communication. Looking at Hyatt's forecast and models, we're comfortable with the range we communicated: $145 million to $160 million, which represents growth from 29% to 42% over the $112 million they achieved in 2024.”
CFO, Usana Health Sciences Inc Q4 FY2024 Earnings Call ·

Affiliation history

Company network

Leadership on record at Usana Health Sciences Inc

Recent activity

Show 7 earlier activities